8-K: TOMI Environmental Solutions Q1 2026 Preliminary Revenue Up 67%

Sentiment:

Preliminary Financial Results Announcement


TOMI Environmental Solutions announced preliminary Q1 2026 revenue of approximately $1.7 million, a 67% sequential increase, with an integrated projects pipeline of $5.3 million.

Better than expectedPreliminary revenue of $1.7 million shows a 67% sequential increase over Q4 2025.Standalone applicator sales have increased by 139% compared to the entire previous year.The integrated projects pipeline has grown to $5.3 million, indicating strong future demand.

Summary

  • TOMI Environmental Solutions reported preliminary unaudited revenue of approximately $1.7 million for the first quarter of 2026.
  • This represents a significant 67% sequential increase compared to the fourth quarter of 2025.
  • The company's pipeline for integrated projects, including those awaiting approval or under contract, has grown to $5.3 million, involving 14 customers.
  • First quarter sales combined with current open orders reached approximately $3,360,000.
  • Sales of standalone applicators using patented cold plasma arc technology surpassed the entire previous year's sales, showing a 139% increase.
  • BIT Solution sales were approximately $427,000, and iHP Corporate Service sales totaled approximately $729,000 in orders.
  • A significant $440,000 annual purchase order for decontamination services was secured with a leading global medical technology company.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive report due to significant sequential revenue growth, a strong project pipeline, and substantial increases in specific product sales, indicating robust operational performance and market demand.

Positives

  • Strong sequential revenue growth of 67% from Q4 2025 to Q1 2026, reaching approximately $1.7 million.
  • Integrated projects pipeline increased to $5.3 million, indicating future revenue potential.
  • Standalone applicator sales increased by 139% compared to the entire previous year.
  • Secured a substantial $440,000 annual purchase order for decontamination services with a major medical technology company.
  • Increased utilization of equipment and support offerings by customers, reflected in higher sales across various segments.
  • Management expresses confidence in the ongoing growth trajectory of the iHP Corporate Service business.

Negatives

  • The preliminary financial results are unaudited and subject to customary adjustments.
  • Reliance on a single or a few products for a majority of revenues is a potential risk mentioned in forward-looking statements.

Risks

  • Potential for actual results to differ materially from forward-looking statements due to various risks and uncertainties.
  • Ability to acquire new customers and expand sales.
  • Projected revenue and revenue recognized from anticipated future purchase orders, invoiced orders, and contracts.
  • Ability to maintain and manage growth and generate sales.
  • Reliance on a single or a few products for a majority of revenues.
  • General business and economic conditions.
  • Other risks as described in SEC filings, including the Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

Future Outlook

The company anticipates continued growth in the iHP Corporate Service business for 2026 and beyond, supported by strategic partnerships and increasing customer utilization of equipment and services. The company expects to file its full financial results for Q1 2026 in due course.

Management Comments

  • Management's confidence in the ongoing growth trajectory of the iHP Corporate Service business for 2026 and beyond is highlighted.
  • Dr. Shane highlighted management's confidence during the last earnings call.

Industry Context

StockSavvy.ai notes that TOMI Environmental Solutions' preliminary Q1 2026 results, showing strong sequential revenue growth and an expanding project pipeline, align with a broader industry trend towards increased demand for advanced disinfection and decontamination solutions, particularly in life sciences and healthcare sectors.

Stakeholder Impact

  • Shareholders: Potential for increased valuation and returns due to strong revenue growth and positive outlook.
  • Customers: Continued access to advanced disinfection and decontamination solutions, with increased availability of applicators and ongoing service agreements.
  • Employees: Potential for business expansion and growth, possibly leading to increased opportunities.

Next Steps

  • File full financial results for the first quarter of 2026.
  • File Quarterly Report on Form 10-Q with the Securities and Exchange Commission.

Key Dates

DateDescription
April 8, 2026Date of Report (Date of earliest event reported)
April 8, 2026Press release announcing preliminary financial results for Q1 2026
March 31, 2026End of the first quarter of 2026
2024Year the global medical technology company first engaged TOMI for decontamination
December 31, 2025Fiscal year end for the Annual Report on Form 10-K

Recommendation

hold

While the preliminary results show strong sequential growth and positive trends, the unaudited nature of the results and the inherent risks outlined in forward-looking statements warrant a cautious approach. A 'hold' recommendation allows investors to await the full audited financial results and further assess the sustainability of this growth before making a stronger commitment.

Keywords

TOMI Environmental Solutions, SteraMist, iHP, decontamination, disinfection, revenue growth, Q1 2026, financial results

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.